| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $50.0M | +0.0% |
| R&D Expense | $71.7M | -16.8% |
| SG&A Expense | $116.3M | +114.2% |
| Operating Income | -$188.0M | -33.9% |
| Pre-tax Income | -$180.1M | -42.2% |
| Income Tax | $3.4M | — |
| Net Income | -$183.4M | -44.9% |
| EPS (Basic) | -$3.69 | -7.3% |
| EPS (Diluted) | -$3.69 |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $131.6M | +314.0% |
| Current Assets | $241.7M | +7.1% |
| Total Assets | $250.8M | +6.5% |
| Current Liabilities | $45.2M | +98.0% |
| Stockholders' Equity | $95.4M | -53.8% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$152.9M | -71.4% |
| Capital Expenditures | $434K | +933.3% |
| Investing Cash Flow | $91.0M | +207.4% |
| Financing Cash Flow | $159.7M | +6.0% |
| Free Cash Flow | -$153.3M | -71.8% |
| -7.3% |